135 related articles for article (PubMed ID: 38773179)
1. Role of peritumoral tissue analysis in predicting characteristics of hepatocellular carcinoma using ultrasound-based radiomics.
Qian H; Huang Y; Xu L; Fu H; Lu B
Sci Rep; 2024 May; 14(1):11538. PubMed ID: 38773179
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the Ki-67 marker index in hepatocellular carcinoma based on CT radiomics features.
Wu H; Han X; Wang Z; Mo L; Liu W; Guo Y; Wei X; Jiang X
Phys Med Biol; 2020 Dec; 65(23):235048. PubMed ID: 32756021
[TBL] [Abstract][Full Text] [Related]
3. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
4. Predicting Ki-67 expression in hepatocellular carcinoma: nomogram based on clinical factors and contrast-enhanced ultrasound radiomics signatures.
Zhang D; Zhang XY; Lu WW; Liao JT; Zhang CX; Tang Q; Cui XW
Abdom Radiol (NY); 2024 May; 49(5):1419-1431. PubMed ID: 38461433
[TBL] [Abstract][Full Text] [Related]
5. Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation.
Wu JP; Ding WZ; Wang YL; Liu S; Zhang XQ; Yang Q; Cai WJ; Yu XL; Liu FY; Kong D; Zhong H; Yu J; Liang P
Int J Hyperthermia; 2022; 39(1):595-604. PubMed ID: 35435082
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
[TBL] [Abstract][Full Text] [Related]
7. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
[TBL] [Abstract][Full Text] [Related]
8. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
9. Development of an interpretable machine learning model for Ki-67 prediction in breast cancer using intratumoral and peritumoral ultrasound radiomics features.
Wang J; Gao W; Lu M; Yao X; Yang D
Front Oncol; 2023; 13():1290313. PubMed ID: 38044998
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
[TBL] [Abstract][Full Text] [Related]
12. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma.
Liu HF; Wang M; Wang Q; Lu Y; Lu YJ; Sheng Y; Xing F; Zhang JL; Yu SN; Xing W
Insights Imaging; 2024 Mar; 15(1):97. PubMed ID: 38536542
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
Yang X; Yuan C; Zhang Y; Wang Z
Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
[TBL] [Abstract][Full Text] [Related]
15. Preoperative diagnosis and prediction of hepatocellular carcinoma: Radiomics analysis based on multi-modal ultrasound images.
Yao Z; Dong Y; Wu G; Zhang Q; Yang D; Yu JH; Wang WP
BMC Cancer; 2018 Nov; 18(1):1089. PubMed ID: 30419849
[TBL] [Abstract][Full Text] [Related]
16. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis.
Qian GX; Xu ZL; Li YH; Lu JL; Bu XY; Wei MT; Jia WD
World J Gastroenterol; 2024 Apr; 30(15):2128-2142. PubMed ID: 38681988
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
[TBL] [Abstract][Full Text] [Related]
19. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
Chen Y; Xia Y; Tolat PP; Long L; Jiang Z; Huang Z; Tang Q
AJR Am J Roentgenol; 2021 Jun; 216(6):1510-1520. PubMed ID: 33826360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
